Related references
Note: Only part of the references are listed.Insulin-like growth factor-1 receptor as a novel prognostic marker and its implication as a cotarget in the treatment of human adenocarcinoma of the esophagus
Tatyana Kalinina et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Neoadjuvant Strategies for the Treatment of Locally Advanced Esophageal Cancer
John R. Hyngstrom et al.
JOURNAL OF SURGICAL ONCOLOGY (2010)
Activated leukocyte cell adhesion molecule expression predicts lymph node metastasis in oral squamous cell carcinoma
Michiel van den Brand et al.
ORAL ONCOLOGY (2010)
Randomized Clinical Trials in Esophageal Carcinoma
Stephen A. Barnett et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2010)
Label-free detection of cancer biomarker candidates using surface plasmon resonance imaging
Jon Ladd et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2009)
Strong Impact of Micrometastatic Tumor Cell Load in Patients with Esophageal Carcinoma
Alexandra M. Koenig et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera
Hana Vaisocherova et al.
BIOSENSORS & BIOELECTRONICS (2009)
Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse
C. Kahlert et al.
BRITISH JOURNAL OF CANCER (2009)
Inflammation A driving force speeds cancer metastasis
Yadi Wu et al.
CELL CYCLE (2009)
Activated leukocyte cell adhesion molecule: A novel biomarker for breast cancer
Vathany Kulasingam et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Predicting Systemic Disease in Patients With Esophageal Cancer After Esophagectomy A Multinational Study on the Significance of the Number of Involved Lymph Nodes
Christian G. Peyre et al.
ANNALS OF SURGERY (2008)
Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer
M. Ihnen et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer
Nikolas H. Stoecklein et al.
CANCER CELL (2008)
Attenuation of melanoma invasion by a secreted variant of activated leukocyte cell adhesion molecule
Jeroen W. J. van Kilsdonk et al.
CANCER RESEARCH (2008)
Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients
Delia Mezzanzanica et al.
CLINICAL CANCER RESEARCH (2008)
Clinical significance of p53 alterations in surgically treated prostate cancers
Thorsten Schlomm et al.
MODERN PATHOLOGY (2008)
Activated leukocyte cell adhesion molecule: a new paradox in cancer
Solomon F. Ofori-Acquah et al.
TRANSLATIONAL RESEARCH (2008)
The ALCAM shedding by the metalloprotease ADAM17/TACE is involved in motility of ovarian carcinoma cells
Ombretta Rosso et al.
MOLECULAR CANCER RESEARCH (2007)
Staging of esophageal cancer by EUS: staging accuracy revisited
Rahul A. Shimpi et al.
GASTROINTESTINAL ENDOSCOPY (2007)
Quality control of endoscopic ultrasound in preoperative staging of esophageal cancer
A. Kutup et al.
ENDOSCOPY (2007)
Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagus
Uta Reichelt et al.
MODERN PATHOLOGY (2007)
Effectiveness of radical en-bloc-esophagectomy compared to transhiatal esophagectomy in squamous cell cancer of the esophagus is influenced by nodal micrometastases
Emize F. Yekebas et al.
JOURNAL OF SURGICAL ONCOLOGY (2006)
L1 (CD171) is highly expressed in gastrointestinal stromal tumors
JT Kaifi et al.
MODERN PATHOLOGY (2006)
Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer
JT Kaifi et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
MEMD/ALCAM: A potential marker for tumor invasion and nodal metastasis in esophageal squamous cell carcinoma
A Verma et al.
ONCOLOGY (2005)
ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival
W Weichert et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions
G Kristiansen et al.
PROSTATE (2003)
Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer.
S Braun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
